Immunotherapy for advanced or relapsed cervical cancer
Cervical cancer is the third most commonly diagnosed cancer and the fourth leading cause of cancer deaths worldwide. Conventional approaches by surgery, radiotherapy, and/or chemotherapy cannot provide satisfied therapeutic outcomes for advanced or relapsed cervical cancer. Thus, immunotherapy or bi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2013-02-01
|
| Series: | Gynecology and Minimally Invasive Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213307012000330 |